Keratoacanthoma clinical behavior: A systematic review

American Journal of Dermatopathology

Volumn 36, Issue 5, 2014, Pages 422-429

  Savage, Jacqueline A ^a   Maize, John C ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

biologic behavior; controversy; keratoacanthoma; squamous cell carcinoma

Indexed keywords

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER MORTALITY; CELLULAR IMMUNITY; FOLLOW UP; HISTOLOGY; HUMAN; KERATOACANTHOMA; METASTASIS; PERINEURAL INVASION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CARCINOMA; SYSTEMATIC REVIEW; WIDE EXCISION; PATHOLOGY; SKIN DISEASE;

HUMANS; KERATOACANTHOMA; SKIN DISEASES;

EID: 84900845893     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0000000000000031     Document Type: Article

References (137)

1. Cerroni L, Kerl H. Keratoacanthoma. In: Goldsmith LA, Katz SI, Gilchrest BA, et al, eds. Fitzpatricks Dermatology in General Medicine. New York, NY: McGraw-Hill; 2012.
2. Rook A, Whimster I. Keratoacanthoma-A thirty year retrospect. Br J Dermatol. 1979;100:41-47.
3. Brewer JD. Keratoacanthoma: epidemiology, risk factors, and diagnosis. UpToDate. Available at: www.uptodate.com. Accessed May 5, 2013.
4. Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009;26:150-163.
5. Goudie DR, DAlessandro M, Merriman B, et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet. 2011;43:365-369.
6. Ponti G, Losi L, Pedroni M, et al. Value of MLH1 and MSH2 in the appearance of Muir-Torre syndrome phenotype in HNPCC patientspresenting sebaceous gland tumors or keratoacanthomas. J Invest Dermatol. 2006;126:2302-2307.
7. Youn SM, Lee JH, Park WS, et al. No association between genitalmucosal human papilloma virus infection and keratoacanthoma in Korean patients. J Cutan Pathol. 2011;38:256-258.
8. Kulkarni RP, Plaisier S, Ra SH, et al. Genetic profiling of BRAF inhibitorinduced keratoacanthomas reveals no induction of MAP kinase pathway expression. J Invest Dermatol. 2013;133:830-833.
9. Patel NP, Cervino AL. Treatment of keratoacanthoma: is intralesional methotrexate an option? Can J Plast Surg. 2011;19:E15-E18.
10. Farias MM, Hasson A, Navarrete C, et al. Efficacy of topical photodynamic therapy for keratoacanthomas: a case-series of four patients. Indian J Dermatol Venereol Leprol. 2012;78:172-174.
11. Griffiths RW. Keratoacanthoma observed. Br J Plast Surg. 2004;57: 485-501.
12. Oakley A, Ng S. Grzybowskis generalized eruptive keratoacanthoma: remission with cyclophosphamide. Australas J Dermatol. 2005;46: 118-123.
13. Agarwal M, Chander R, Karmakar S, et al. Multiple familial keratoacanthoma of Witten and Zak-A report of three siblings. Dermatology. 1999;198:396-399.
14. Vandergriff T, Nakamura K, High WA. Generalized eruptive keratoacanthomas of Grzybowski treated with isotretinoin. J Drugs Dermatol. 2008;7:1069-1071.
15. Goldberg LH, Silapunt S, Beyrau KK, et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol. 2004;50:753-758.
16. Chesnut GT, Maggio KL, Turiansky GW. Re: case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg. 2011;37:884-885.
17. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamouscell carcinoma: three examples with metastases. Am J Dermatopathol. 1993;15:332-342.
18. Weedon DD, Malo J, Brooks D, et al. Squamous cell carcinoma arising in keratoacanthoma: a neglected phenomenon in the elderly. Am J Dermatopathol. 2010;32:423-426.
19. Kossard S, Tan KB, Choy C. Keratoacanthoma and infundibulocystic squamous cell carcinoma. Am J Dermatopathol. 2008;30: 127-134.
20. Misago N, Inoue T, Toda S, et al. Infundibular (follicular) and infundibulocystic squamous cell carcinoma: a clinicopathological and immunohistochemical study. Am J Dermatopathol. 2011;33:687-694.
21. Beham A, Regauer S, Soyer HP, et al. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol. 1998;5:269-280.
22. Weedon DD, Malo J, Brooks D, et al. Keratoacanthoma: is it really a variant of squamous cell carcinoma? ANZ J Surg. 2010;80:129-130.
23. Piscioli F, Zumiani G, Boi S, et al. A gigantic, metastasizing keratoacanthoma: report of a case and discussion of classification. Am J Dermatopathol. 1984;6:123-129.
24. Peterkin GA, Macmillan JB, Maclean S. Pseudo-carcinoma of the skin: a follow-up of cases of keratoacanthoma seen in the 10 years 1951-60. Scott Med J. 1962;7:27-35.
25. Silberberg I, Kopf AW, Baer RL. Recurrent keratoacanthoma of the lip. Arch Dermatol. 1962;86:44-53.
26. Wolinsky S, Silvers DN, Kohn SR, et al. Spontaneous regression of a giant keratoacanthoma: photographic documentation and histopathologic correlation. J Dermatol Surg Oncol. 1981;7:897-901.
27. Givner I, Kallos A, Medine M, et al. Keratoacanthoma: report of 2 cases. Am J Ophthalmol. 1960;49:822-824.
28. Ritchlin HW, Gensheimer RJ. Subungual keratoacanthoma: a case report. J Am Podiatr Med Assoc. 1981;71:503-504.
29. Levy EJ, Cahn MM, Shaffer B, et al. Keratoacanthoma. JAMA. 1954; 155:562-564.
30. Whittle CH, Davis RA. Kerato-Acanthoma of lower lip red margin. Lancet. 1957;272:1019-1020.
31. Aubut N, Alain J, Claveau J. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series. J Cutan Med Surg. 2012;16:212-217.
32. Magalhaes RF, Cruvinel GT, Cintra GF, et al. Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases. J Cutan Med Surg. 2008;12:163-173.
33. Sayama S, Tagami H. Treatment of keratoacanthoma with intralesional bleomycin. Br J Dermatol. 1983;109:449-452.
34. Webb AJ, Ghadially FN. Massive or giant keratoacanthoma. J Pathol Bacteriol. 1966;91:505-509.
35. Ko CJ, McNiff JM, Bosenberg M, et al. Keratoacanthoma: clinical and histopathologic features of regression. J Am Acad Dermatol. 2012;67: 1008-1012.
36. Annest NM, VanBeek MJ, Arpey CJ. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol. 2007;56:989-993.
37. Moriyama M, Watanabe T, Sakamoto N, et al. A case of giant keratoacanthoma of the auricle. Auris Nasus Larynx. 2000;27:185-188.
38. Pattee SF, Silvis NG. Keratoacanthoma developing in sites of previous trauma: a report of two cases and review of the literature. J Am Acad Dermatol. 2003;48:S35-S38.
39. Denkler K, Kivett WF. Topical treatment of nasal keratoacanthoma. Plast Reconstr Surg. 2006;117:2516-2517.
40. Lejman J, Starzycki Z. Giant keratoacanthoma on the inner surface of the prepuce. Br J Vener Dis. 1977;53:65-67.
41. Odom RB, Goette DK. Treatment of keratoacanthomas with intralesional fluorouracil. Arch Dermatol. 1978;114:1779-1783.
42. Chauhan A, Chaudhary S, Agnihotri PG, et al. A solitary crateriform ulcer of the lower lip: a case report with review of literature. Indian J Dermatol. 2011;56:435-438.
43. Browne F, OConnell M, Merchant W, et al. Spontaneous resolution of a giant keratoacanthoma penetrating through the nose. Clin Exp Dermatol. 2011;36:369-371.
44. Shah M, Green L, Kwok C. Self-resolving invasive squamous cell carcinoma or giant keratoacanthoma? Clin Exp Dermatol. 2012;37: 701-702.
45. Tulvatana W, Pisarnkorskul P, Wannakrairot P. Solitary keratoacanthoma of the conjunctiva: report of a case. J Med Assoc Thai. 2001;84: 1059-1064.
46. Mangas C, Bielsa I, Ribera M, et al. A case of multiple keratoacanthoma centrifugum marginatum. Dermatol Surg. 2004;30:803-806.
47. Cecchi R, Troiano M, Buralli L, et al. Recurrent distal digital keratoacanthoma of the periungual region treated with Mohs micrographic surgery. Australas J Dermatol. 2012;53:e5-e7.
48. Perdigo FB, Pierre-Filho Pde T, Natalino RJ, et al. Conjunctival keratoacanthoma. Rev Hosp Clin Fac Med Sao Paulo. 2004;59:135-137.
49. Elliott GB, Fisher BK. Perianal keratoacanthoma. Arch Dermatol. 1967; 95:81-82.
50. Dei Rossi C, Peserico A, Simonetto D. Keratoacanthoma centrifugum marginatum. Arch Dermatol. 1977;113:110.
51. Macaulay WL. Subungual keratoacanthoma. Arch Dermatol. 1976;112: 1004-1005.
52. Ozkan F, Bilgic R, Cesur S. Vulvar keratoacanthoma. APMIS. 2006; 114:562-565.
53. Hughes EH, Intzedy L, Dick AD, et al. Keratoacanthoma of the conjunctiva. Eye. 2003;17:781-782.
54. Sinha A, Marsh R, Langtry J. Spontaneous regression of subungual keratoacanthoma with reossification of underlying distal lytic phalynx. Clin Exp Dermatol. 2005;30:20-22.
55. Underhill T. Subungual keratoacanthoma: the importance of accurate diagnosis. J Hand Surg (Eur Vol). 2010;35:599-600.
56. Heine KG. Treatment of multiple keratoacanthomas with fluorouracil. J Ky Med Assoc. 1983;81:94-96.
57. Aydin F, Senturk N, Sabanciler E, et al. A case of Ferguson-Smith type multiple keratoacanthomas associated with keratoacanthoma centrifugum marginatum: response to oral acitretin. Clin Exp Dermatol. 2007;32:683-686.
58. Kato N, Ito K, Kimura K, et al. Ferguson Smith type multiple keratoacanthomas and a keratoacanthoma centrifugum marginatum in a woman from Japan. J Am Acad Dermatol. 2003;49:741-746.
59. Sanders S, Busam KJ, Halpern AC, et al. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy. Dermatol Surg. 2002;28:954-958.
60. Rosenblum GA. Multiple palmar keratoacanthomas treated with acitretin. J Drugs Dermatol. 2006;5:1006-1009.
61. DeAmbrosis K, DeAmbrosis B. Nonmelanoma skin cancer with perineural invasion: report of outcomes of a case series. Dermatol Surg. 2010;36:133-138.
62. Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: a report of 40 cases. Australas J Dermatol. 2001;42:168-171.
63. Basoglu Y, Metze D, Nashan D, et al. Keratoacanthoma with perineural invasion: an indicator for aggressive behavior? J Dtsch Dermatol Ges. 2008;6:952-955.
64. Petrie M, Eliezri Y, Campanelli C. Keratoacanthoma of the head and neck with perineural invasion: incidental finding or cause for concern? Dermatol Surg. 2010;36:1209-1213.
65. Calonje E, Jones EW. Intravascular spread of keratoacanthoma. An alarming but benign phenomenon. Am J Dermatopathol. 1992;14:414-417.
66. Kurien A, Henderson C, Lee S. Recurrent keratoacanthoma with vascular invasion: a diagnostic and management dilemma. Australas J Dermatol. 2009;50:194-197.
67. Rhatigan RM, Nuss RC. Keratoacanthoma of the vulva. Gynecol Oncol. 1985;21:118-123.
68. Mohr B III, Fernandez MP, Krejci-Manwaring J. Eruptive keratoacanthomas after Jessners and trichloroacetic acid peel for actinic keratosis. Dermatol Surg. 2013;39:331-333.
69. Cecchi R, Bartoli L, Brunetti L, et al. Topical imiquimod in the treatment of large facial keratoacanthomas. G Ital Dermatol Venereol. 2012; 147:505-507.
70. Foxton G, Delaney T. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin. Australas J Dermatol. 2011;52:66-69.
71. Balagula Y, Busam KJ, Carvajal RD, et al. Keratoacanthomas associated with imatinib mesylate. Acta Oncol. 2011;50:593-595.
72. Davies KD, Davies JH. A widespread, itchy papular eruption. Clin Exp Dermatol. 2010;35:937-939.
73. Arun B, Harries M, Jamieson L, et al. Multiple nodule on the arms and legs. Clin Exp Dermatol. 2010;35:931-932.
74. Yeon JH, Jung JY, Choi JW, et al. Keratoacanthoma aggravated after photodynamic therapy. J Dermatol. 2010;37:765-766.
75. Yazdani N, Khorsandi-Ashtiani M, Rabbani-Anari M, et al. Nasal vestibular huge keratoacanthoma: an unusual site. Pak J Biol Sci. 2009;12: 1385-1387.
76. Robertson SJ, Bashir SJ, Pichert G, et al. Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin. Clin Exp Dermatol. 2010;35:e100-e102.
77. Arnault JP, Wechsler J, Escudier B, et al. Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib. J Clin Oncol. 2009;27:e59-e61.
78. Pini AM, Koch S, Schrer L, et al. Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient. J Am Acad Dermatol. 2008;59:S116-S117.
79. Karaa A, Khachemoune A. Tumor with central crusting. J Fam Pract. 2008;57:669-671.
80. Calista D, Morri M. Topical imiquimod for the treatment of keratoacanthomas. Eur J Dermatol. 2008;18:590-591.
81. Paterno EJ, Campione E, Diluvio L, et al. Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma. Dermatol Online J. 2008;14:8. Available at: http://dermatology.cdlib. org. Accessed May 3, 2013.
82. Souza CS, Felicio LB, Arruda D, et al. Systemic photodynamic therapy as an option for keratoacanthoma centrifugum marginatum treatment. J Eur Acad Dermatol Venereol. 2009;23:101-102.
83. Naudi KB, Critchlow HA, Hunter KD. Keratoacanthoma of the gingiva-A pathological conundrum. Oral Oncol. 2009;45:e9-e10.
84. Aroni K, Mastoraki A, Agrogiannis G, et al. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream. Int J Dermatol. 2007;46:1321-1322.
85. VIckova-Laskoska MT, Laskoski DS. Keratoacanthoma centrifugum marginatum: a rare atypical variant of keratoacanthoma. Clin Exp Dermatol. 2008;33:259-261.
86. Chorny JA, Stephens FV, Cohen JL. Eruptive keratoacanthomas in a new tattoo. Arch Dermatol. 2007;143:1457-1458.
87. Vergara A, Isarra MJ, Domnguez JD, et al. Multiple and relapsing keratoacanthomas developing at the edge of the skin grafts site after surgery and after radiotherapy. Dermatol Surg. 2007;33:994-996.
88. Minicucci EM, Weber SA, Stolf HO, et al. Keratoacanthoma of the lower lip complicating discoid lupus erythematosus in a 14-year-old boy. Pediatr Dermatol. 2007;24:329-330.
89. Ujiie H, Kato N, Natsuga K, et al. Keratoacanthoma developing on nevus sebaceous in a child. J Am Acad Dermatol. 2007;56:S57-S58.
90. Sheyner I, Osipov V. Keratoacanthoma arising after an arthropod sting. J Am Geriatr Soc. 2006;54:1972-1973.
91. Ratnapala D, Lambrianides A, Mahoney H. Keratoacanthoma centrifugum marginatum. ANZ J Surg. 2006;76:277-278.
92. Attili Sk, Attili VR. Keratoacanthoma centrifugum marginatum arising in vitiligo: a case report. Dermatol Online J. 2006;12:18.
93. Yuge S, Godoy DA, Melo MC, et al. Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil. J Am Acad Dermatol. 2006;54:S218-S219.
94. Prvanescu H, Mogoanta L, Foarfa C, et al. Giant keratoacanthoma of the hand. Rom J Morphol Embryol. 2005;46:235-238.
95. Kaptanoglu AF, Kutluay L. Keratoacanthoma developing in previous cryotherapy site for solar keratosis. J Eur Acad Dermatol Venereol. 2006;20:197-198.
96. Kurschat P, Hess S, Hunzelmann N, et al. Keratoacanthoma centrifugum marginatum accompanied by extensive granulomatous foreign body reaction. Dermatol Online J. 2005;11:16. Available at: http://dermatology. cdlib.org. Accessed May 3, 2013.
97. Leibovitch I, Huilgol SC, James CL, et al. Periocular keratoacanthoma: can we always rely on the clinical diagnosis? Br J Ophthalmol. 2005; 89:1201-1204.
98. Nascimento MC, Cominos D, Davies NJ, et al. Vulval Keratoacanthoma: a case report. Gynecol Oncol. 2005;97:674-676.
99. Thiele JJ, Ziemer M, Fuchs S, et al. Combined 5-fluorouracil and Er: YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg. Dermatol Surg. 2004;30:1556-1560.
100. Oh CK, Son HS, Lee JB, et al. Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol. 2004;51:S177-S180.
101. Di Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol. 2004;18:626-629.
102. Chen W, Koenig C. Vulvar keratoacanthoma: a report of two cases. Int J Gynecol Pathol. 2004;23:284-286.
103. Kimyai-Asadi A, Shaffer C, Levine VJ, et al. Keratoacanthoma arising from an excisional surgery scar. J Drugs Dermatol. 2004;3:193-194.
104. Giesecke LM, Reid CM, James CL, et al. Giant keratoacanthoma arising in hypertrophic lichen planus. Australas J Dermatol. 2003;44:267-269.
105. Donaldson MJ, Sullivan TJ, Whitehead KJ, et al. Periocular keratoacanthoma: clinical features, pathology, and management. Ophthalmology. 2003;110:1403-1407.
106. Ogasawara Y, Kinoshita E, Ishida T, et al. A case of multiple keratoacanthoma centrifugum marginatum: response to oral etretinate. J Am Acad Dermatol. 2003;48:282-285.
107. Schwartz RA, Blaszczyk M, Jablonska S. Generalized eruptive keratoacanthoma of Grzybowski: follow-up of the original description and 50-year retrospect. Dermatology. 2002;205:348-352.
108. Kifuku K, Yoshikawa H, Sonoda KH, et al. Conjunctival keratoacanthoma in an Asian. Arch Ophthalmol. 2003;121:118-119.
109. Sardana K, Sarkar R, Garg VK, et al. Multinodular keratoacanthoma: a rare but definite entity. Int J Dermatol. 2002;41:905-907.
110. de Visscher JG, van der Wal KG, Blanken R, et al. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report. J Oral Maxillofac Surg. 2002;60:93-95.
111. Radakovic-Fijan S, Honigsmann H, Tanew A. Efficacy of topical photodynamic therapy of a giant keratoacanthoma demonstrated by partial irradiation. Br J Dermatol. 1999;141:936-938.
112. Andreassi A, Pianigiani E, Taddeucci P, et al. Guess what! keratoacanthoma treated with intralesional bleomycin. Eur J Dermatol. 1999;9: 403-405.
113. Coupland SE, Heimann H, Kellner U, et al. Keratoacanthoma of the bulbar conjunctiva. Br J Ophthalmol. 1998;82:586.
114. Cuesta-Romero C, de Grado-Pena J. Intralesional methotrexate in solitary keratoacanthoma. Arch Dermatol. 1998;134:513-514.
115. de la Torre C, Losada A, Cruces MJ. Keratoacanthoma centrifugum marginatum: treatment with intralesional bleomycin. J Am Acad Dermatol. 1997;37:1010-1011.
116. Dessoukey MW, Omar MF, Abdel-Dayem H. Eruptive keratoacanthomas associated with immunosuppressive therapy in a patient with systemic lupus erythematosus. J Am Acad Dermatol. 1997; 37:478-480.
117. Schellini SA, Marques ME, Milanezi MF, et al. Conjunctival keratoacanthoma. Acta Ophthalmol Scand. 1997;75:335-337.
118. Gilbey S, Moore DH, Look KY, et al. Vulvar keratoacanthoma. Obstet Gynecol. 1997;89:848-850.
119. Janette A, Pecaro B, Lonergan M, et al. Solitary intraoral keratoacanthoma: report of a case. J Oral Maxillofac Surg. 1996;54:1026-1030.
120. Hurst LN, Gan BS. Intralesional methotrexate in keratoacanthoma of the nose. Br J Plast Surg. 1995;48:243-246.
121. Cooper PH,Wolfe JT III. Perioral keratoacanthomas with extensive perineural invasion and intravenous growth. Arch Dermatol. 1988;124:1397-1401.
122. Hamed LM, Wilson FM II, Grayson M. Keratoacanthoma of the limbus. Ophthalmic Surg. 1988;19:267-270.
123. Pagani WA, Lorenzi G, Lorusso D. Surgical treatment for aggressive giant keratoacanthoma of the face. J Dermatol Surg Oncol. 1986;12:282-284.
124. Bergin DJ, Lapins NA, Deffer TA. Intralesional 5-fluorouracil for keratoacanthoma of the eyelid. Ophthal Plast Reconstr Surg. 1986;2:201-204.
125. Goette DK. Treatment of keratoacanthoma with topical fluorouracil. Arch Dermatol. 1983;119:951-953.
126. Weedon D, Barnett L. Keratoacanthoma centrifugum marginatum. Arch Dermatol. 1975;111:1024-1026.
127. Tarnowski WM. Multiple keratoacanthomata. Response of a case to systemic chemotherapy. Arch Dermatol. 1966;94:74-80.
128. Spieth K, Gille J, Kaufmann R. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip. Dermatology. 2000;200:317-319.
129. Lucente FE. Giant keratoacanthoma of the nose. Otolaryngol Head Neck Surg. 1985;93:112-116.
130. Ramos LM, Cardoso SV, Loyola AM, et al. Keratoacanthoma of the inferior lip: review and report of case with spontaneous regression. J Appl Oral Sci. 2009;17:262-265.
131. Griffiths RW, Feeley K, Suvarna SK. Audit of clinical and histological prognostic factors in primary invasive squamous cell carcinoma of the skin: assessment in a minimum 5 year follow-up study after conventional excisional surgery. Br J Plast Surg. 2002;55:287-292.
132. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28: 268-273.
133. Mullen JT, Feng L, Xing Y, et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006;13:902-909.
134. Davis BA, Monheit GD, Kline L. Metastatic skin cancer presenting as ptosis and diplopia. Dermatol Surg. 2006;32:148-158.
135. Riahi RR, Cohen PR. Clinical manifestations of cutaneous metastases: a review with special emphasis on cutaneous metastases mimicking keratoacanthoma. Am J Clin Dermatol. 2012;13:103-112.
136. Reich A, Kobierzycka M, Wozniak Z, et al. Keratoacanthoma-like cutaneous metastasis of lung cancer: a learning point. Acta Derm Venereol. 2006;86:459-460.
137. Weedon DD. Tumors of cutaneous apendages. In: Weedon DD ed. Weedons Skin Pathology. Edinburgh, United Kingdom: Churchill Livingstone/Elsevier; 2010:758-807.